|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.36 USD | -2.18% |
|
-15.82% | -28.21% |
| 05:05pm | Legend Biotech's Stock Weakness After Rival Treatment Update 'Overdone,' RBC Says | MT |
| 12-08 | UBS Adjusts Legend Biotech Price Target to $48 From $54, Maintains Buy Rating | MT |
Insiders
Search
10-14 | CI | |
08-18 | CI | |
08-18 | RE | |
08-18 | MT | |
08-18 | CI | |
06-16 | MT | |
06-05 | CI | |
01-02 | MT | |
12-24 | MT | |
12-24 | MT | |
12-23 | CI | |
11-04 | CI | |
08/08/24 | CI | |
11/03/24 | CI | |
11/04/23 | CI | |
03/04/23 | CI | |
17/10/22 | CI | |
04/08/22 | CI | |
10/05/22 | MT | |
09/05/22 | MT | |
03/04/22 | CI | |
01/04/22 | CI | |
30/12/21 | CI | |
03/12/20 | CI | |
23/11/20 | CI |
No results for this search
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition